About the webinar: Multimodal imaging has evolved as a key technology in preclinical research, combining morphological, functional and molecular imaging. Prof. Ogris will share the approaches his team uses to over the limitations of 2-D optical imaging and the new multimodal imaging developments coming from his work.
About the speaker: Dr. Ogris is a professor of Pharmaceutical Sciences at the University of Vienna. He studied Biotechnology and graduated from the University of Live Sciences in Vienna. After a Postdoctoral stay at the CRC Institute of Cancer Research, University of Birmingham/UK, he joined the Ludwig-Maximilians-University Munich as a workgroup leader with a research focus on cancer gene therapy. In 2013, he was appointed as a full professor at the University Vienna, where he founded and heads the MMCT lab. The lab has a strong focus on the development of macromolecular formulations for targeted drug and nucleic acid based therapies and uses multimodal imaging to study their pharmacokinetics and pharmacodynamics.
There will be an interactive Q&A discussion after the presentation.
Register now and become part of the conversation.